Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
ASCO 2014 roundup
Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers
Targeted drug combo, cediranib plus olaparib, significantly increases progression-free survival in recurrent ovarian cancer
Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer
Role of AORTIC in dealing with rising cancer rates in Africa
Role of genomics in assessing risk, especially in ovarian cancer
Prevention of cervical cancer through control of HPV virus
The global control and prevention of cervical cancer caused by HPV
Recent advances in surgery, radiotherapy and targeted treatment for cervical cancer
Cancer cells and the immune system: a natural story?
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction